Motor Network Physiology
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Jun 29, 2021
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Motor Network Physiology," is exploring how certain brain circuits work when people have movement disorders like Parkinson's disease and essential tremor. The researchers want to understand how treatments like deep brain stimulation (DBS) and medication, such as levodopa, can help improve movement by changing the way these brain networks communicate. They believe that issues in the brain's motor circuits can lead to symptoms like stiffness and slow movement, and they aim to learn more about these changes during surgery when patients are awake.
To participate in this study, individuals must be diagnosed with Parkinson's disease and recommended for deep brain stimulation to manage their movement issues. They should also be able to stay awake and cooperate for up to 40 minutes during the procedure. However, those who have recently taken blood-thinning medications or have certain cognitive impairments may not be eligible. Participants can expect to undergo surgery while researchers monitor brain activity and how it responds to stimulation and medication, providing valuable insights into improving treatments for these conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Parkinson's disease who have been recommended to undergo deep brain stimulation for management of their movement disorder
- • Preoperative MRI without evidence of cortical or subdural adhesions or vascular abnormalities
- • Willingness and ability to cooperate during conscious operative procedure for up to 40 minutes
- Exclusion Criteria:
- • Patients with recent use (within one week) of anticoagulant or antiplatelet agents
- • Neurocognitive testing indicating amnestic cognitive deficits
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Nader Pouratian, MD, PhD
Principal Investigator
University of Texas Southwestern Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials